Creating groundbreaking new drugs from monoclonal antibodies targeting GPCRs.
We publish information related to the research and development of antibodies targeting GPCRs.
This document introduces an interview with NBI Health Research Institute (Sapporo City), a biotech venture specialized in the development of monoclonal antibody drugs targeting G protein-coupled receptors (GPCRs). It includes efforts to produce antibodies against GPCRs, including G proteins. [Contents] ■ Controlling information transmission related to diseases ■ Capturing proteins exposed on the extracellular surface ■ High-speed flow cytometry as the key ■ The frontier spirit of Hokkaido blossoms *For more details, please refer to the PDF document or feel free to contact us.
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
